{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:02:03Z","timestamp":1746331323951,"version":"3.40.4"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.2169\/internalmedicine.4289-24","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:14:24Z","timestamp":1728598464000},"page":"1350-1354","source":"Crossref","is-referenced-by-count":0,"title":["Primary Neuroendocrine Carcinoma of the Anal Canal with Cancer Genome Profiling"],"prefix":"10.2169","volume":"64","author":[{"given":"Ryuichi","family":"Morita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Sugeta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juichiro","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Japanese Red Cross Society Kyoto Daiichi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasuku","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Fuji","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyoto Saiseikai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nagtegaal ID, Odze RD, Klimstra D, et al.; the WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology 76: 182-188, 2020.","DOI":"10.1111\/his.13975"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ueberroth BE, Liu AJ, Starr JS, et al. Neuroendocrine carcinoma of the anus and rectum: patient characteristics and treatment options. Clin Colorectal Cancer 20: e139-e149, 2021.","DOI":"10.1016\/j.clcc.2020.12.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 47: 163-169, 2004.","DOI":"10.1007\/s10350-003-0038-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Smith J, Reidy-Lagunes D. The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas. Semin Oncol 40: 100-108, 2013.","DOI":"10.1053\/j.seminoncol.2012.11.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 45: 234-243, 2010.","DOI":"10.1007\/s00535-009-0194-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kobayashi H, Kurokawa T, Shimizu M, et al. A case of neuroendocrine carcinoma of the anal canal. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 79: 2139-2144, 2018.","DOI":"10.3919\/jjsa.79.2139"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Otsuka M, Kato Y. Clinicopathological study of poorly differentiated and undifferentiated of the large intestine - classification and special reference to the endocrine cell carcinoma. Jpn J Gastroenterol Surg 25: 1248-1256, 1992.","DOI":"10.5833\/jjgs.25.1248"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hirose K, Shinohara T, Saji Y. A case of neuroendocrine cell carcinoma of the rectum. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 65: 1620-1624, 2004.","DOI":"10.3919\/jjsa.65.1620"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol 56: 1033-1044, 2021.","DOI":"10.1007\/s00535-021-01827-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sashiyama H, Hamahata Y, Tsutsumi O, Hoshino T, Tsujinaka Y. A case of neuroendocrine cell carcinoma of the anal canal. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 71: 2682-2686, 2010.","DOI":"10.3919\/jjsa.71.2682"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takeshima K, Yamafuji K, Asami A, et al. A long survival case of endocrine cell carcinoma of the cecum. Nihon Shokakibyo Geka Gakkai Zasshi (Jpn J Gastroenterol Surg) 40: 757-763, 2007.","DOI":"10.5833\/jjgs.40.757"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yasui Y, Ono N, Matsubara M, Sato Y. A case of endocrine cell carcinoma of the anal canal. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 65: 3249-3252, 2004.","DOI":"10.3919\/jjsa.65.3249"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ohtomo R, Sekine S, Taniguchi H, Tsuda H, Moriya Y, Kushima R. Anal canal neuroendocrine carcinoma associated with squamous intraepithelial neoplasia: a human papillomavirus 18-related lesion. Pathol Int 62: 356-359, 2012.","DOI":"10.1111\/j.1440-1827.2012.02800.x"},{"key":"14","unstructured":"14. Morizane C, Machida N, Honma Y, et al.; the Japan Clinical Oncology Group (JCOG). Effectiveness of etoposide and cisplatin vs irinotecan and cisplatin therapy for patients with advanced neuroendocrine carcinoma of the digestive system: the TOPIC-NEC phase 3 randomized clinical trial. JAMA Oncol 8: 1447-1455, 2022."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Garcia-Carbonero R, Sorbye H, Baudin E, et al.; Vienna Concensus Conference participants. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology 103: 186-194, 2016.","DOI":"10.1159\/000443172"},{"key":"16","unstructured":"16. Sunami K. The challenges of drug provision in cancer genome medicine. J Hered Tumors 21: 101-104, 2022."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yachida S, Totoki Y, No\u00eb M, et al. Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system. Cancer Discov 12: 692-711, 2022.","DOI":"10.1158\/2159-8290.CD-21-0669"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Knudsen ES, Kumarasamy V, Nambiar R, et al. CDK\/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities. Cell Rep 38: 110448, 2022.","DOI":"10.1016\/j.celrep.2022.110448"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ooi A, Oyama T, Nakamura R, et al. Gene amplification of <i>CCNE1<\/i>, <i>CCND1<\/i>, and <i>CDK6<\/i> in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. Hum Pathol 61: 58-67, 2017.","DOI":"10.1016\/j.humpath.2016.10.025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Condorelli R, Spring L, O&apos;Shaughnessy J, et al. Polyclonal <i>RB1<\/i> mutations and acquired resistance to CDK 4\/6 inhibitors in patients with metastatic breast cancer. Ann Oncol 29: 640-645, 2018.","DOI":"10.1093\/annonc\/mdx784"},{"key":"21","unstructured":"21. Goyal L, Meric-Bernstam F, Hollebecque A, et al.; the FOENIX-CCA2 Study Investigators. Futibatinib for <i>FGFR2<\/i>-rearranged intrahepatic cholangiocarcinoma. N Engl J Med 388: 228-239, 2023."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kabu K, Takei S, Kondo M, Kitazawa K, Harada T. Pharmacological characteristics and clinical study results of Pemigatinib (Pemazyre<sup>\u00ae<\/sup> Tablets), a selective fibroblast growth factor receptor (FGFR) inhibitor. Nihon Yakurigaku Zasshi (Folia Pharmacol Jpn) 156: 392-402, 2021.","DOI":"10.1254\/fpj.21087"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4289-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:01:08Z","timestamp":1746244868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/9\/64_4289-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4289-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"article-number":"4289-24"}}